Clinical Trial Update: The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome [Phase 4]

View source ↗

Summary

An ongoing Phase 4 clinical study led by The Chaim Sheba Medical Center is examining psychiatric and cognitive phenotypes in 22q11.2 deletion syndrome, Williams…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q11 Deletion Syndrome
• Fragile Syndrome
• Williams Syndrome

Snippet

Sponsor: The Chaim Sheba Medical Center | Conditions: Velocardiofacial Syndrome, Williams Syndrome | Phase 4 | Status: RECRUITING